NCT06127056

Brief Summary

To investigate the intervention effect of high-definition transcranial alternating current stimulation (HD-tACS) on patients with Non-suicidal Self-injury (NSSI) and its underlying neural mechanism by magnetic resonance imaging (MRI).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

November 7, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 13, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

November 14, 2023

Status Verified

November 1, 2023

Enrollment Period

1.2 years

First QC Date

November 7, 2023

Last Update Submit

November 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in the number, frequency, and impulsivity of self-injurious behaviors

    Adolescent Non-suicidal self-injury Assessment Questionnaire consisted of 2 dimensions and 12 items, with 5 options for each item, namely, "none, occasional, sometimes, often, and always", and was scored on a 5-point Likert scale from 0 to 4. The score for each item was summed up as the total score of the questionnaire, and the total mean score was divided by the number of items. The total mean score was divided by the number of items, and the higher the total mean score, the more serious the patients' non-suicidal Likert 5 self-injurious behaviors were.

    baseline and immediately after the intervention

Secondary Outcomes (3)

  • Change in Hamilton Depression Rating Scale (HAMD) Score

    baseline and immediately after the intervention

  • Change in Hamilton Anxiety Scale (HAMA) Score

    baseline and immediately after the intervention

  • Change in Patient Health Questionnaire-15 (PHQ-15) Score

    baseline and immediately after the intervention

Study Arms (2)

real stimulation

ACTIVE COMPARATOR

The central electrode was placed over F3, with return electrodes at Fp1, Fz, F7 and C3. Fourteen 2-mA sessions (ramp-up and ramp-down periods of 15 and 15 seconds, respectively) were applied for 20 minutes per session, twice daily over 7 consecutive days, and the stimulus frequency was set as IAF.

Device: High-Definition Transcranial Alternating Current Stimulation (HD-tACS)

sham stimulation

SHAM COMPARATOR

In the sham condition, tACS was delivered only during the ramp-up and ramp-down periods (15 and 15 s); no current was delivered during the 20-minute intervention. Participants will receive sham tACS twice daily for two weeks.

Device: sham High-Definition Transcranial Alternating Current Stimulation (HD-tACS)

Interventions

tACS is described as a non-invasive form of brain stimulation that uses a low-intensity, alternating current applied directly to the head through scalp electrodes.

real stimulation

In the sham condition, tACS was delivered only during the ramp-up and ramp-down periods (15s and 15s); no current was delivered during the 20-minute intervention.

sham stimulation

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The patients were diagnosed by 2 or more senior clinical psychiatrists, meeting DSM-V criteria, and having 1 or more non-suicidal self-injurious behaviors in the last 6 months.
  • years of age.
  • The medicine has not changed in the 4 weeks prior to or after this study, and if it has to be changed, the treatment medication is required to be at a subtherapeutic dosage level.

You may not qualify if:

  • The patient has suicidal ideation or has committed suicidal behavior
  • T1 or T2 weighted phase magnetic resonance images show focal brain lesions
  • patients had neurological disorders such as epilepsy, or serious physical illnesses
  • patients had a history of substance abuse and drug dependence in the last 6 months or use of anticonvulsant drugs in the last 3 months
  • patients had received radial cranial electrical stimulation or magnetic stimulation treatment in the last 3 months or received electroconvulsive therapy in the last 6 months
  • patients had previous significant head trauma or EEG abnormality in the last 1 month
  • body-mounted devices unsuitable for treatment, such as pacemakers, artificial valves, and other metal implants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Anhui Medical University

Hefei, Anhui, China

RECRUITING

MeSH Terms

Conditions

Self-Injurious Behavior

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • Yanghua Tian, PhD

    Anhui Medical University

    STUDY CHAIR

Central Study Contacts

Yanghua Tian, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head, Dept of Neurology & Medical Psychology, Director, Cognitive Neuropsychology Lab, PRC

Study Record Dates

First Submitted

November 7, 2023

First Posted

November 13, 2023

Study Start

May 1, 2023

Primary Completion

July 30, 2024

Study Completion

July 30, 2024

Last Updated

November 14, 2023

Record last verified: 2023-11

Locations